MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Medtronic plc
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026
$92.77−1.98 (-2.09%)
Close on Oct 19, 2026
- Market cap
- $119.22B
- P/E (TTM)
- 22.8
- Dividend yield
- 3.06%
Medtronic statistics
Financials through Jul 31, 2026, price as of Oct 19, 2026, median of Electromedical & Electrotherapeutic Apparatus companies for comparison
Valuation
| Measure | Medtronic | Industry median |
|---|---|---|
| Market Cap | $118.67B | $229.23M |
| Enterprise Value | $138.62B | $194.73M |
| PE Ratio | 22.79 | 33.41 |
| PS Ratio | 3.16 | 3.14 |
| PB Ratio | 2.36 | 3.19 |
| P/FCF Ratio | 19.35 | 27.25 |
| P/OCF Ratio | 14.77 | 22.23 |
Enterprise value
| Measure | Medtronic | Industry median |
|---|---|---|
| EV / Sales | 3.69 | 2.93 |
| EV / EBITDA | 14.25 | 19.97 |
| EV / EBIT | 20.42 | 25.47 |
| EV / FCF | 22.61 | 27.85 |
Income (trailing twelve months)
| Measure | Medtronic | Industry median |
|---|---|---|
| Revenue | $37.54B | $102.39M |
| Gross Profit | $24.41B | $60.36M |
| Operating Income | $6.79B | -$4.31M |
| Pretax Income | $6.60B | -$2.26M |
| Net Income | $5.23B | -$6.57M |
| EBITDA | $9.73B | -$1.98M |
| EPS (Diluted) | $4.07 | -$0.07 |
Margins
| Measure | Medtronic | Industry median |
|---|---|---|
| Gross Margin | 65.0% | 55.1% |
| Operating Margin | 18.1% | -6.04% |
| Pretax Margin | 17.6% | -4.11% |
| Profit Margin | 13.9% | -10.5% |
| EBITDA Margin | 25.9% | -2.67% |
| FCF Margin | 16.3% | -0.30% |
Returns
| Measure | Medtronic | Industry median |
|---|---|---|
| Return on Equity (ROE) | 10.7% | -19.2% |
| Return on Assets (ROA) | 5.68% | -13.3% |
| Return on Invested Capital (ROIC) | 7.85% | -4.11% |
| Return on Capital Employed (ROCE) | 8.33% | -9.07% |
Growth
| Measure | Medtronic | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 9.77% | 8.85% |
| Net Income Growth (YoY) | 12.3% | 10.6% |
| EPS Growth (YoY) | 12.1% | 10.6% |
| FCF Growth (YoY) | 15.6% | 10.6% |
| Revenue Growth (3Y CAGR) | 5.21% | 7.08% |
| Revenue Growth (5Y CAGR) | 3.84% | 11.8% |
| EPS Growth (3Y CAGR) | 9.77% | 3.06% |
| EPS Growth (5Y CAGR) | 7.00% | 7.64% |
Balance sheet
| Measure | Medtronic | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $8.82B | $37.33M |
| Total Debt | $28.15B | $72.66M |
| Net Cash (Debt) | -$19.33B | $3.92M |
| Net Cash Per Share | -$15.11 | $0.28 |
| Equity (Book Value) | $50.23B | $57.36M |
| Book Value Per Share | $39.27 | $2.81 |
| Tangible Book Value | -$3.19B | $10.71M |
| Working Capital | $12.59B | $54.64M |
Financial position
| Measure | Medtronic | Industry median |
|---|---|---|
| Current Ratio | 2.07 | 2.50 |
| Quick Ratio | 1.29 | 1.54 |
| Debt / Equity | 0.56 | 0.38 |
| Debt / EBITDA | 2.89 | 2.31 |
| Debt / FCF | 4.59 | 3.50 |
| Net Debt / EBITDA | 1.99 | 1.53 |
| Interest Coverage | 9.37 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Medtronic | Industry median |
|---|---|---|
| Operating Cash Flow | $8.04B | -$653.46K |
| Capital Expenditures | -$1.90B | -$3.69M |
| Free Cash Flow | $6.13B | -$835.02K |
| FCF Per Share | $4.79 | -$0.02 |
Efficiency
| Measure | Medtronic | Industry median |
|---|---|---|
| Asset Turnover | 0.41 | 0.59 |
| Inventory Turnover | 2.17 | 2.21 |
| Revenue Per Employee | $395.17K | $322.75K |
| Profits Per Employee | $55.06K | -$52.11K |
| Employee Count | 95,000 | 197 |
Dividends and yields
| Measure | Medtronic | Industry median |
|---|---|---|
| Earnings Yield | 4.41% | -6.92% |
| FCF Yield | 5.17% | -0.62% |
| Dividend Yield | 3.06% | 0.81% |
| Buyback Yield | 0.99% | 0.78% |
| Shareholder Yield | 4.05% | 0.84% |
| Dividend Per Share | $2.84 | $0.72 |
| Dividend Growth (YoY) | 1.43% | 4.80% |
| Years of Dividend Growth | 11 | 0 |
| Payout Ratio | 69.8% | 30.3% |
| FCF Payout Ratio | 59.5% | 21.9% |
Shares
| Measure | Medtronic | Industry median |
|---|---|---|
| Shares Outstanding | 1,279,140,000 | 44,856,700 |
| Shares Change (YoY) | 0.05% | 3.35% |
| Shares Change (QoQ) | -0.01% | 0.27% |
| Float | 1,277,890,000 | 36,934,400 |
| Shares Held by Insiders | 0.10% | 10.6% |
| Shares Held by Institutions | 86.5% | 63.5% |
Taxes
| Measure | Medtronic | Industry median |
|---|---|---|
| Income Tax | $1.33B | $1.52M |
| Effective Tax Rate | 20.2% | 18.6% |
Scores
| Measure | Medtronic | Industry median |
|---|---|---|
| Graham Number | $59.97 | $34.37 |
| Graham Upside | -35.4% | -58.3% |
| Altman Z-Score | 2.98 | 1.95 |
| Piotroski F-Score | 7 | 5 |
| Beneish M-Score | -2.58 | -2.64 |
Calculated by StockData from Medtronic's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.